26 August 2015 – The Board of Directors of Anteo Diagnostics (ASX: ADO) (Anteo) is pleased to announce that it will acquire DIAsource ImmunoAssays, SA (DIAsource), an established global specialty
Continue
Anteo Diagnostics Limited (ASX:ADO) (“Anteo” or the “Company”), released a copy of the presentation that Joshua Soldo delivered to a full house at the AACC OEM Lecture Series on Tuesday
Continue
Leading up to AACC, Anteo announced the distribution of their Mix&Go™ product range through Sigma-Aldrich. Mix&Go Reagents, Coupling and Activation Kits are expected to be available during Q3 of CY2015.
Continue
SCIENION, a leading global provider of ultra-low volume precision liquid handling systems, and Australian biotech company Anteo Technologies today announced that they have partnered to co-develop protein microarray consumables using
Continue
Today Anteo Technologies Pty Ltd (a subsidiary of Anteo Diagnostics Limited, ASX: ADO) is pleased to announce the launch of a research partnership with the Australian Institute for Bioengineering and
Continue